Back to search
FDAFDA · Food and drugs·Recall number D-0200-2026

Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.

Published December 10, 2025 · Recall initiated: September 17, 2025

Summary

FDA records drug Class II recall D-0200-2026, published December 10, 2025 and initiated September 17, 2025. Recalling firm: Park Avenue Compounding; Status: Ongoing; Reported quantity: 858 syringes; Lot: Lot # 20250813-13D65E, Exp Date: FEB-09-2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Park Avenue Compounding
Distributor
MO
Lot
Lot # 20250813-13D65E, Exp Date: FEB-09-2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1. recalled?

Yes. FDA published recall D-0200-2026 on December 10, 2025. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter